UPCOMING webcasts:

Live on September 13, 2010 at
10:20 a.m. ET (7:20 a.m. PT)
Replay available until September 27, 2010
 

 

 

Nexavar, which is being developed and marketed in collaboration with Bayer HealthCare Pharmaceuticals, is currently being evaluated in a number of randomized clinical trials in other tumor types.